Abstract:Background Long intergenic non-protein coding RNA 1140 (LINC01140), a long non-coding RNA, is highly expressed in various cancers; however, its biological functions in lung cancer (LC) progression and immune escape are still unclear. Methods Here, to elucidate LINC01140 function, 79 paired LC and paracancerous tissues were collected. LINC01140 expression levels were determined using fluorescence in situ hybridization and qPCR analysis. Cell counting kit-8 (CCK-8) assay and transwell assays were performed. The interaction between microRNAs (miRNAs) and LINC01140 was confirmed using an RNA immunoprecipitation assay. Cytokine-induced killer (CIK) cell phenotypes were analyzed by flow cytometry. Cytokine secretion levels were determined by ELISA. CIK cytotoxicity was assessed by measuring lactate dehydrogenase release. Besides, xenograft tumor mouse models were used to unveil the in vivo function of LINC01140. Results We found that LINC01140 was highly expressed in human LC tissues and cell lines. High LINC01140 levels were associated with poor survival in patients with LC. LINC01140 upregulation promoted the proliferation, migration, and invasion of LC cells through direct interaction with miR-33a-5p and miR-33b-5p, thereby contributing to c-Myc expression and also inhibited cisplatin-induced cell apoptosis. In subcutaneous tumor xenograft mice, LINC01140 knockdown markedly reduced tumor growth and lung metastasis. Additionally, LINC01140 directly repressed miR-377-3 p and miR-155-5 p expression levels, resulting in the upregulation of their common downstream target programmed death-ligand 1 (PD-L1), a crucial target in LC immunotherapy. Notably, we proved that LINC01140 knockdown, along with CIK administration, suppressed the growth of subcutaneous LC xenografts by decreasing PD-L1 expression in severe combined immunodeficient mice. Conclusions Taken together, LINC01140 overexpression protects c-Myc and PD-L1 mRNA from miRNA-mediated inhibition and contributes to the proliferation, migration, invasion, and immune escape of LC cells. These results provide a theoretical basis that LINC01140 is a promising target for LC treatment.

Silencing of LINC00461 Enhances Radiosensitivity of Lung Adenocarcinoma Cells by Down-Regulating HOXA10 Via Microrna-195

Downregulated long intergenic non-coding RNA 00,174 represses malignant biological behaviors of lung cancer cells by regulating microRNA-584-3p/ribosomal protein S24 axis

Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells Via Targeting HOXA10

LINC00662 Promotes Melanoma Progression by Competitively Binding Mir-107 and Activating the Β-Catenin Signaling Pathway.

A Novel Long Non-Coding RNA LINC00355 Promotes Proliferation of Lung Adenocarcinoma Cells by Down-Regulating Mir-195 and Up-Regulating the Expression of CCNE1.

Silencing of the long non-coding RNA LINC00265 triggers autophagy and apoptosis in lung cancer by reducing protein stability of SIN3A oncogene

LINC00968 Can Inhibit the Progression of Lung Adenocarcinoma Through the Mir-21-5p/smad7 Signal Axis.

Long Noncoding RNA LINC00520 Accelerates Lung Adenocarcinoma Progression Via Mir-1252-5p/foxr2 Pathway

LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs

Linc00467 Promotes Lung Adenocarcinoma Proliferation Via Sponging Mir-20B-5p to Activate CCND1 Expression.

The Long Noncoding RNA LINC00665 Facilitates c-Myc Transcriptional Activity via the miR-195-5p MYCBP Axis to Promote Progression of Lung Adenocarcinoma

Silencing LINC00511 Inhibits Cell Proliferation, Migration and EMT Via PTEN/AKT/FOXO1 Signaling Pathway in Lung Cancer.

Silencing of LINC01116 Suppresses the Development of Oral Squamous Cell Carcinoma by Up-Regulating Microrna-136 to Inhibit FN1.

LINC00511 Promotes Lung Squamous Cell Carcinoma Proliferation and Migration Via Inhibiting Mir-150-5p and Activating TADA1

Ott_a_207748 6733..6743

Silencing of lncRNA H19 Enhances the Sensitivity to X-rays and Carbon-Ions Through the miR-130a-3p /WNK3 Signal Axis in Non-Small-Cell Lung Cancer Cells

Downregulation of LINC00115 inhibits the proliferation and invasion of lung cancer cells in vitro and in vitro

LINC00891 Regulated by Mir-128-3p/gata2 Axis Impedes Lung Cancer Cell Proliferation, Invasion and EMT by Inhibiting RhoA Pathway.

Long Non-coding RNA LINC00628 Interacts Epigenetically with the LAMA3 Promoter and Contributes to Lung Adenocarcinoma

Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells

Dysregulated <i>LINC00961</i> Contributes to the Vitality and Migration of NSCLC Via miR-19a-3p/miR-19b-3p/miR-125b-5p